Suchergebnisse - "McDonald, Kerrie L"

PubPharm (9)

1

NUTMEG : A randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed older patients with glioblastoma

enthalten in: Neuro-oncology advances | 2023

von Sim, H. | Wachsmuth, L. | Barnes, E. | +26

2

A randomized phase II trial of veliparib, radiotherapy, and temozolomide in patients with unmethylated MGMT glioblastoma : the VERTU study

enthalten in: Neuro-oncology | 2021

von Sim, H. | McDonald, K. | Lwin, Z. | +15

3

Genome-wide investigation of intragenic DNA methylation identifies ZMIZ1 gene as a prognostic marker in glioblastoma and multiple cancer types

enthalten in: International journal of cancer | 2019

von Mathios, D. | Hwang, T. | Xia, Y. | +19

4

A case study of a long-term glioblastoma survivor with unmethylated MGMT and hypermutated genotype

enthalten in: Cold Spring Harbor molecular case studies | 2019

von Jue, T. | Olafson, L. | Siddell, A. | +10

5

Impact of the H3K27M mutation on survival in pediatric high-grade glioma : a systematic review and meta-analysis

enthalten in: Journal of neurosurgery. Pediatrics | 2018

von Lu, V. | Alvi, M. | McDonald, K. | +1

6

Realizing the therapeutic potential of rare earth elements in designing nanoparticles to target and treat glioblastoma

enthalten in: Nanomedicine (London, England) | 2017

von Lu, V. | McDonald, K. | Townley, H.

7

CDK4/6 Inhibitor PD0332991 in Glioblastoma Treatment : Does It Have a Future?

enthalten in: Frontiers in oncology | 2015

von Schröder, L. | McDonald, K.

8

Role of Biomarkers in the Clinical Management of Glioblastomas : What are the Barriers and How Can We Overcome Them?

enthalten in: Frontiers in neurology | 2012

von McDonald, K. | Aw, G. | Kleihues, P.

9

Integrated genomic analyses identify ERRFI1 and TACC3 as glioblastoma-targeted genes

enthalten in: Oncotarget | 2010

von Duncan, C. | Killela, P. | Payne, C. | +11

CommentIn: Oncotarget. 2010 Aug;1(4):237-8. - PMID 21304175

1
[1]